| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
LONDON—With diminishing pipelines and the dramatic growth of the East Asian pharmaceutical industry, interest in natural products and traditional Chinese medicines (TCMs) as a source of novel therapeutics is increasing. With this in mind, researchers at King's College London undertook a systematic analysis of the TCM landscape using informatics tools.
 
In the first of two papers in the Journal of Chemical Information and Modeling, the researchers scanned primary and secondary literature sources to establish two databases of information about TCMs. As they explained, basic biological and chemical data about these herbs exist in a variety of locations but not in formats easily parsed for data mining and molecular modeling.
 
The Chinese Herb Chemistry Database (CHCD) examines approximately 7000 unique compounds identified in 240 species of Chinese herbs, including information on compound structure, trivial and systematic names, compound class and skeletal type, chirality, CAS Registry number, pharmacology and toxicology, as well as other data. The Bioactive Plant Compounds Database (BPCD) meanwhile also includes information about molecular targets, ligand type, inhibition data, and botanical species.
 
In the second paper, the researchers used ligand-based virtual screening to identify potential molecular targets of an array of herbal compounds. They relied on an ensemble decision tree algorithm, Random Forest, to highlight similarities between known target ligands and herbal compounds.
 
Screening more than 8000 compounds from 240 herb species, the researchers noted that most of the compounds were 2- to 3-orders of magnitude less potent than typical pharmaceuticals (i.e., IC50 1-100 µM). At the same time, they found that more than 60 percent of the herbs offered hits for one or more targets, and that half of these hit two or more targets. They then used the literature to check their results and found evidence to support 83 herb-target predictions, suggesting the system works well.
 
"What this work shows is that the relatively new science of molecular informatics may have much to offer in furthering our understanding of how herbs work, and in developing new, and perhaps safer, medicines based on nature's own resources," says co-author Dr. Tom Ehrman.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue